Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Russian strikes kill 12 in Kyiv as Ukraine runs low on air defences
25 dead, 100 injured in clashes at Sri Lanka prison, sources say
Six killed in India's Mumbai as rains wreak havoc, disrupt travel
Thousands evacuated from homes in southwest France as wildfire burns
Folarin Balogun to play for US after FIFA suspends red-card ban